Botanical species · safety record

Polyscias fruticosa

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 adverse-effect records for Polyscias fruticosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Polyscias fruticosa (L.) Harms

4Constituent measurements

2Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Polyacetylene derivatives	Roots and other underground parts	Solvent extraction	0.003 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Saponins	Roots and other underground parts	Solvent extraction	0.49 Percent	Unspecified	No resolvable identifier
Saponins	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Saponins	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Unspecified	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Unspecified	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Lutomski, J., Luan, T. C. Polyacetylenes in the Araliaceae family. Part III. The qualitative and quantitative determination of the polyacetylenes from the crude extracts of Panax vietnamensis Ha et Grushv. and Polyscias fruticosa (L.) Harms. by thin layer chromatography and spectrophotometry. Herba polonica, 1992, p. 53-61.
Mai, Truong Tuyet., Thu, Nghiem Nguyet., Tien, Pham Gia., Van Chuyen, Nguyen. Alpha-glucosidase inhibitory and antioxidant activities of Vietnamese edible plants and their relationships with polyphenol contents . Journal of nutritional science and vitaminology, 2007, vol. 53, no. 3, p. 267-276. DOI
Vo Xuan Minh., Pham Huu Duong., Le Thanh Ha. Study of chemical composition and dosage form of Polyscias fruticosa Harm. Tap chi duoc hoc, 1991, p. 19-21.
Huan, VD., Yamamura, S., Ohtani, K., Kasai, R., Yamasaki, K., Nham, NT., Chau, HM. Oleanane saponins from Polyscias fruticosa. PHYTOCHEMISTRY, 1998, vol. 47, no. 3, p. 451-457.
Bernard, B M., Pakianathan, N., Venkataswamy, R., Divakar, M C. A pharmacognostic report on the leaf and root of polyscias fruticosa (L.) harms. . Ancient science of life, 1998, vol. 18, no. 2, p. 165-72.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature